ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.98
0.14%
Dow Jones
38,943.57
0.23%
US Dollar vs MXN
16.84819
-0.22%
Brent Oil
82.43
-1.25%
Bitcoin
63,359.72
0.31%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Spero Therapeutics Inc (SPRO)

  7. Spero Therapeutics Inc (SPRO) Noticias

SPRO

Spero Therapeutics (SPRO)

Spero Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SPRO
FechaHoraFuenteTítuloSímboloCompañía
06/03/202407:05GlobeNewswire Inc.Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024NASDAQ:SPROSpero Therapeutics Inc
28/02/202407:05GlobeNewswire Inc.Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial InfectionsNASDAQ:SPROSpero Therapeutics Inc
26/02/202407:05GlobeNewswire Inc.Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare ConferenceNASDAQ:SPROSpero Therapeutics Inc
09/02/202415:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPROSpero Therapeutics Inc
05/02/202419:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPROSpero Therapeutics Inc
05/02/202415:50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SPROSpero Therapeutics Inc
31/01/202415:05GlobeNewswire Inc.Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SPROSpero Therapeutics Inc
05/01/202407:05GlobeNewswire Inc.Spero Therapeutics Provides Corporate Update and 2024 OutlookNASDAQ:SPROSpero Therapeutics Inc
02/01/202407:05GlobeNewswire Inc.Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract InfectionsNASDAQ:SPROSpero Therapeutics Inc
15/11/202315:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SPROSpero Therapeutics Inc
13/11/202315:50Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SPROSpero Therapeutics Inc
13/11/202315:05GlobeNewswire Inc.Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business UpdateNASDAQ:SPROSpero Therapeutics Inc
13/11/202315:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SPROSpero Therapeutics Inc
13/11/202305:45IH Market NewsMonday’s Wall Street Highlights: Boeing, Novo Nordisk, Moody’s, StoneCo, and moreNASDAQ:SPROSpero Therapeutics Inc
06/11/202307:05GlobeNewswire Inc.Spero Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on Monday, November 13, 2023NASDAQ:SPROSpero Therapeutics Inc
01/11/202315:05GlobeNewswire Inc.Spero Therapeutics to Present at Upcoming November Investor ConferencesNASDAQ:SPROSpero Therapeutics Inc
01/11/202307:05GlobeNewswire Inc.Spero Therapeutics Appoints Esther Rajavelu as Chief Financial Officer and Chief Business OfficerNASDAQ:SPROSpero Therapeutics Inc
16/10/202315:01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:SPROSpero Therapeutics Inc
20/09/202315:05GlobeNewswire Inc.Spero Therapeutics to Present at Cantor’s Global Healthcare 2023 Investor ConferenceNASDAQ:SPROSpero Therapeutics Inc
06/09/202307:05GlobeNewswire Inc.Spero Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:SPROSpero Therapeutics Inc
01/09/202315:11Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:SPROSpero Therapeutics Inc
01/09/202315:08Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SPROSpero Therapeutics Inc
22/08/202316:27Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SPROSpero Therapeutics Inc
10/08/202315:05GlobeNewswire Inc.Spero Therapeutics Announces Second Quarter 2023 Operating Results and Provides a Business UpdateNASDAQ:SPROSpero Therapeutics Inc
03/08/202307:05GlobeNewswire Inc.Spero Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023NASDAQ:SPROSpero Therapeutics Inc
31/07/202311:59Dow Jones NewsSpero Therapeutics Shares Rise 14% After Special Protocol Assessment Agreement With FDANASDAQ:SPROSpero Therapeutics Inc
31/07/202307:51Dow Jones NewsSpero Therapeutics in Special Protocol Assessment Agreement for Phase 3 Trial of Tebipenem HBrNASDAQ:SPROSpero Therapeutics Inc
31/07/202307:05GlobeNewswire Inc.Spero Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 PIVOT-PO Trial of Tebipenem HBrNASDAQ:SPROSpero Therapeutics Inc
14/06/202307:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SPROSpero Therapeutics Inc
14/06/202307:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SPROSpero Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SPRO

Su Consulta Reciente

USOTC
BASFY
BASF (QX)
NASDAQ
MSFT
Microsoft
NASDAQ
GOOGL
Alphabet
SPI
SP500
S&P 500
NYSE
MRK
Merck
NYSE
JPM
JP Morgan Chase
PM
XAUUSD
Gold vs US Dollar
USOTC
DTEGY
Deutsche Telekom (QX)
USI
USTECH100
US Tech 100
NYSE
VZ
Verizon Communications
NYSE
DIS
Walt Disney
FX
EURMXN
Euro vs MXN
USOTC
RHHBY
Roche (QX)
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
AMZN
Amazon.com
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados